{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:10:16Z","timestamp":1787015416539,"version":"build-2736575974"},"reference-count":48,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Angiotensin\u2010receptor blockers are often considered insufficiently efficacious in reducing blood pressure. However, newer angiotensin\u2010receptor blockers may be more effective than the older ones. A network meta\u2010analysis was performed to compare the efficacy of various angiotensin\u2010receptor blockers in reducing office and ambulatory blood pressure in hypertensive patients. Relevant literature was searched from English and Chinese databases for randomized controlled trials involving angiotensin\u2010receptor blockers in hypertension. Efficacy variables included systolic and diastolic blood pressure either in the office or on ambulatory blood pressure monitoring. Absolute blood pressure reductions at 6\u201012\u00a0weeks of treatment and their credible intervals were reported. A total of 34 publications provided adequate data for analysis (n\u00a0=\u00a014\u00a0859). In 28 studies on office systolic blood pressure (n\u00a0=\u00a012\u00a0731), against the common comparator valsartan 80\u00a0mg, the differences in systolic blood pressure were in favor of azilsartan medoxomil (20\u201080\u00a0mg), irbesartan (300\u00a0mg), olmesartan (20\u201040\u00a0mg), telmisartan (80\u00a0mg), and valsartan (160\u2010320\u00a0mg), but not candesartan (8\u201016\u00a0mg), losartan (50\u2010100\u00a0mg), irbesartan (150\u00a0mg), olmesartan (10\u00a0mg), and telmisartan (40\u00a0mg). The ranking plot shows that azilsartan medoxomil 80\u00a0mg had a possibility of 99% being the best in the class. Similar results were observed for office diastolic blood pressure and from 13 studies for 24\u2010hour ambulatory systolic and diastolic blood pressure. In conclusion, angiotensin\u2010receptor blockers had different blood pressure lowering efficacy. The newest angiotensin\u2010receptor blocker azilsartan medoxomil at the dose of 80\u00a0mg seemed to be most efficacious in reducing both systolic and diastolic blood pressure in the office and on ambulatory measurement.<\/jats:p>","DOI":"10.1111\/jch.14227","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T22:47:02Z","timestamp":1613861222000},"page":"901-914","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Is the newest angiotensin\u2010receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta\u2010analysis"],"prefix":"10.1111","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-1524","authenticated-orcid":false,"given":"Ji\u2010Guang","family":"Wang","sequence":"first","affiliation":[{"name":"The Shanghai Institute of Hypertension Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Affairs Takeda Pharmaceuticals Ltd Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying\u2010Qing","family":"Feng","sequence":"additional","affiliation":[{"name":"Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2010Sheng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology Beijing Anzhen Hospital Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-3607","authenticated-orcid":false,"given":"Tzung\u2010Dau","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiovascular Center and Divisions of Hospital Medicine and Cardiology Department of Internal Medicine National Taiwan University Hospital and National Taiwan University College of Medicine Taipei City Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1035-5588","authenticated-orcid":false,"given":"Zhi\u2010Ming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Chongqing Hypertension Institute Department of Hypertension and Endocrinology Daping Hospital The Third Military Medical University Chongqing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-4480","authenticated-orcid":false,"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine Department of Medicine Jichi Medical University School of Medicine Tochigi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.07.021"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S22595"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1201"},{"key":"e_1_2_8_7_1","volume-title":"Package GeMTC: Network meta\u2010analysis using Bayesian methods","author":"Valkenhoef G"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/080370598437574"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)00491-3"},{"key":"e_1_2_8_11_1","first-page":"52","article-title":"Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group","volume":"1","author":"Gradman AH","year":"1999","journal-title":"Heart Dis"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00082-5"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00142-9"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000925"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02854844"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2001.00826.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80099-0"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001205"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1524-6175.2002.01586.x","article-title":"Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring","volume":"4","author":"Bakris G","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"e_1_2_8_20_1","first-page":"738","article-title":"Clinical efficacy and safety of telmisartan in patients with mild to moderate hypertension: a multi\u2010center randomized controlled clinical trial","volume":"30","author":"Bai J","year":"2002","journal-title":"Chin J Cardiol"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200404000-00028"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2004.00405.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2004.00409.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.02.016"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2004.00410.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850182"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200525070-00006"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200505010-00006"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2006.00903.x"},{"key":"e_1_2_8_30_1","first-page":"877","article-title":"Efficacy and safety of olmesartan medoxomil versus losartan potassium in Chinese patients with mild to moderate essential hypertension","volume":"34","author":"Zhu J","year":"2006","journal-title":"Chin J Cardiol"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.49"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.06395.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.03.018"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.04.002"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2008.02.003"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2010.00425.x"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.01.2248"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.163402"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2012.05.2549"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-012-0029-5"},{"key":"e_1_2_8_41_1","first-page":"106","article-title":"Efficacy and tolerability of olmesartan, telmisartan, and losartan in patients of stage I hypertension: A randomized, open\u2010label study","volume":"8","author":"Kalikar M","year":"2017","journal-title":"J Pharmacol Pharmacother"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12895"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2013.142"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00237-X"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02028.x"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2012.8"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.06.006"},{"issue":"291","key":"e_1_2_8_48_1","first-page":"48","article-title":"Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonist","volume":"170","author":"Jeong HC","year":"2014","journal-title":"Int J Cardiol"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e3181e1e2da"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.14227","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jch.14227","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.14227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:31:28Z","timestamp":1697074288000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.14227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,20]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1111\/jch.14227"],"URL":"https:\/\/doi.org\/10.1111\/jch.14227","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,20]]},"assertion":[{"value":"2020-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}